Shares of Hims & Hers have gained 29% over the past week. The move higher has been driven by an impressive Q1 earnings report ...

Options volume is more than double the daily average, with 105k contracts traded and calls leading puts for a put/call ratio of 0.53, compared to a typical level near 0.61. Implied volatility (IV30) ...

Here's why these two growth stocks scan as no-brainer buys right now. An emerging powerhouse in telehealth Hims & Hers Health ...

Hims & Hers Health shows impressive operating leverage and a scalable business model, with massive growth potential from new ...

Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The growth of Hims & Hers ...

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...

Nader Kabbani, who led the launch of Amazon Pharmacy and the acquisition of PillPack, will take the chief operating officer ...

Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible ...

As Stat reports, the federal judge's ruling means patients will lose access to less-expensive versions of Eli Lilly's weight loss drug, as well as diabetes treatment Mounjaro, from compounding ...

The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...

Nader Kabbani, who spent almost 20 years at the e-commerce giant, joins the health startup as chief operations officer.